
The potential ischemic benefits of novel oral antiplatelet therapy following an acute coronary syndrome (ACS) may be offset by a significant increase in major bleeding events, according to a meta-analysis recently published in the Archives of Internal Medicine. “We are already exposing these patients to several drugs that can produce…
Read more »
Risk of postnatal fever with misoprostol linked to dosage, administration route
The prostaglandin E1 analog misoprostol is widely used to prevent postpartum hemorrhage, which is the leading cause of maternal death in India. Misoprostol is especially practical in low-resource settings because of its efficacy, cost-effectiveness, and ease of administration (sublingual, oral, vaginal, or rectal). It’s also not heat labile, which makes…
Read more »